VG Life Sciences

Capability details

VG Life Sciences aims to improve and save lives through the development of transformative therapies for drug-resistant cancers and autoimmune diseases. The VG1177 peptide prevents the survival of pro-inflammatory cells that give rise to autoimmune diseases and other disorders. We have completed a pre-investigational new drug meeting with the FDA (IND # 110820)

This is my company
Link me with this company to list Innovations and Challenges